APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Infectious Waste Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Infectious Waste Treatment Market Analysis and Forecast 2026-2032

Report ID 17416390024 June 2026260 pages

Choose your research edition.

Industry ResearchInfectious Waste Treatment Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Infectious Waste Treatment Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Infectious Waste Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Infectious Waste Treatment Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Infectious Waste Treatment Market Analysis and Forecast 2026-2032260 pages · $4,950 USD

Market perspective

The global Infectious Waste Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Infectious Waste Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Infectious Waste Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Infectious Waste Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Infectious Waste Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Infectious Waste Treatment include Veolia, Tesalys, AMB, BEMIS Health Care, Bertin Technologies/CNIM, Bondtech, Celitron Medical Technologies, COMTEM and Red Bag Solutions, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Infectious Waste Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Infectious Waste Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Infectious Waste Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Infectious Waste Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Infectious Waste Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Infectious Waste Treatment revenue, projected growth trends, production technology, application and end-user industry.

Infectious Waste Treatment Segment by Company

Veolia

Tesalys

AMB

BEMIS Health Care

Bertin Technologies/CNIM

Bondtech

Celitron Medical Technologies

COMTEM

Red Bag Solutions

Envomed

Gient

J&T Recycling Corporation

Kayama Kogyo Co., Ltd

HOMEX.Co.,Ltd

KINSEI SANGYO CO.,LTD

TAKUMA Co., Ltd

Infectious Waste Treatment Segment by Type

Equipment

Service

Infectious Waste Treatment Segment by Application

Pathological Waste Treatment

Sharps Waste Treatment

Blood-Contaminated Waste Treatment

Laboratory Infectious Waste Treatment

Others

Infectious Waste Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infectious Waste Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infectious Waste Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infectious Waste Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Infectious Waste Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Infectious Waste Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Infectious Waste Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Infectious Waste Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Equipment Major Player Table 3. Service Major Player Table 4. Global Infectious Waste Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pathological Waste Treatment Major Player Table 6. Sharps Waste Treatment Major Player Table 7. Blood-Contaminated Waste Treatment Major Player Table 8. Laboratory Infectious Waste Treatment Major Player Table 9. Others Major Player Table 10. Infectious Waste Treatment Industry Trends Table 11. Infectious Waste Treatment Industry Drivers Table 12. Infectious Waste Treatment Industry Opportunities and Challenges Table 13. Infectious Waste Treatment Industry Restraints Table 14. Global Infectious Waste Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Infectious Waste Treatment Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Infectious Waste Treatment Market Share by Region (2021-2026) Table 17. Global Infectious Waste Treatment Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Infectious Waste Treatment Market Share by Region (2027-2032) Table 19. Global Infectious Waste Treatment Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Infectious Waste Treatment Revenue Market Share by Players (2021-2026) Table 21. Global Infectious Waste Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Infectious Waste Treatment Key Players Headquarters & Area Served Table 23. Global Infectious Waste Treatment Players, Product Type & Application Table 24. Global Infectious Waste Treatment Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Infectious Waste Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Infectious Waste Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Infectious Waste Treatment Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Infectious Waste Treatment Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Infectious Waste Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Infectious Waste Treatment Revenue Market Share by Type (2027-2032) Table 32. Global Infectious Waste Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Infectious Waste Treatment Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Infectious Waste Treatment Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Infectious Waste Treatment Revenue Market Share by Application (2021-2026) Table 36. Global Infectious Waste Treatment Revenue Market Share by Application (2027-2032) Table 37. Veolia Company Information Table 38. Veolia Business Overview Table 39. Veolia Infectious Waste Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Veolia Infectious Waste Treatment Product Portfolio Table 41. Veolia Recent Development Table 42. Tesalys Company Information Table 43. Tesalys Business Overview Table 44. Tesalys Infectious Waste Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Tesalys Infectious Waste Treatment Product Portfolio Table 46. Tesalys Recent Development Table 47. AMB Company Information Table 48. AMB Business Overview Table 49. AMB Infectious Waste Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. AMB Infectious Waste Treatment Product Portfolio Table 51. AMB Recent Development Table 52. BEMIS Health Care Company Information Table 53. BEMIS Health Care Business Overview Table 54. BEMIS Health Care Infectious Waste Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. BEMIS Health Care Infectious Waste Treatment Product Portfolio Table 56. BEMIS Health Care Recent Development Table 57. Bertin Technologies/CNIM Company Information Table 58. Bertin Technologies/CNIM Business Overview Table 59. Bertin Technologies/CNIM Infectious Waste Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Bertin Technologies/CNIM Infectious Waste Treatment Product Portfolio Table 61. Bertin Technologies/CNIM Recent Development Table 62. Bondtech Company Information Table 63. Bondtech Business Overview Table 64. Bondtech Infectious Waste Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Bondtech Infectious Waste Treatment Product Portfolio Table 66. Bondtech Recent Development Table 67. Celitron Medical Technologies Company Information Table 68. Celitron Medical Technologies Business Overview Table 69. Celitron Medical Technologies Infectious Waste Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Celitron Medical Technologies Infectious Waste Treatment Product Portfolio Table 71. Celitron Medical Technologies Recent Development Table 72. COMTEM Company Information Table 73. COMTEM Business Overview Table 74. COMTEM Infectious Waste Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. COMTEM Infectious Waste Treatment Product Portfolio Table 76. COMTEM Recent Development Table 77. Red Bag Solutions Company Information Table 78. Red Bag Solutions Business Overview Table 79. Red Bag Solutions Infectious Waste Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Red Bag Solutions Infectious Waste Treatment Product Portfolio Table 81. Red Bag Solutions Recent Development Table 82. Envomed Company Information Table 83. Envomed Business Overview Table 84. Envomed Infectious Waste Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Envomed Infectious Waste Treatment Product Portfolio Table 86. Envomed Recent Development Table 87. Gient Company Information Table 88. Gient Business Overview Table 89. Gient Infectious Waste Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Gient Infectious Waste Treatment Product Portfolio Table 91. Gient Recent Development Table 92. J&T Recycling Corporation Company Information Table 93. J&T Recycling Corporation Business Overview Table 94. J&T Recycling Corporation Infectious Waste Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. J&T Recycling Corporation Infectious Waste Treatment Product Portfolio Table 96. J&T Recycling Corporation Recent Development Table 97. Kayama Kogyo Co., Ltd Company Information Table 98. Kayama Kogyo Co., Ltd Business Overview Table 99. Kayama Kogyo Co., Ltd Infectious Waste Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Kayama Kogyo Co., Ltd Infectious Waste Treatment Product Portfolio Table 101. Kayama Kogyo Co., Ltd Recent Development Table 102. HOMEX.Co.,Ltd Company Information Table 103. HOMEX.Co.,Ltd Business Overview Table 104. HOMEX.Co.,Ltd Infectious Waste Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. HOMEX.Co.,Ltd Infectious Waste Treatment Product Portfolio Table 106. HOMEX.Co.,Ltd Recent Development Table 107. KINSEI SANGYO CO.,LTD Company Information Table 108. KINSEI SANGYO CO.,LTD Business Overview Table 109. KINSEI SANGYO CO.,LTD Infectious Waste Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. KINSEI SANGYO CO.,LTD Infectious Waste Treatment Product Portfolio Table 111. KINSEI SANGYO CO.,LTD Recent Development Table 112. TAKUMA Co., Ltd Company Information Table 113. TAKUMA Co., Ltd Business Overview Table 114. TAKUMA Co., Ltd Infectious Waste Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. TAKUMA Co., Ltd Infectious Waste Treatment Product Portfolio Table 116. TAKUMA Co., Ltd Recent Development Table 117. North America Infectious Waste Treatment Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Infectious Waste Treatment Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Infectious Waste Treatment Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Infectious Waste Treatment Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Infectious Waste Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Infectious Waste Treatment Revenue by Country (2021-2026) & (US$ Million) Table 123. North America Infectious Waste Treatment Revenue by Country (US$ Million) & (2027-2032) Table 124. Europe Infectious Waste Treatment Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Infectious Waste Treatment Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Infectious Waste Treatment Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Infectious Waste Treatment Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Infectious Waste Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Infectious Waste Treatment Revenue by Country (2021-2026) & (US$ Million) Table 130. Europe Infectious Waste Treatment Revenue by Country (US$ Million) & (2027-2032) Table 131. China Infectious Waste Treatment Revenue by Type (2021-2026) & (US$ Million) Table 132. China Infectious Waste Treatment Revenue by Type (2027-2032) & (US$ Million) Table 133. China Infectious Waste Treatment Revenue by Application (2021-2026) & (US$ Million) Table 134. China Infectious Waste Treatment Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Infectious Waste Treatment Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Infectious Waste Treatment Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Infectious Waste Treatment Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Infectious Waste Treatment Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Infectious Waste Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Infectious Waste Treatment Revenue by Region (US$ Million) & (2021-2026) Table 141. Asia Infectious Waste Treatment Revenue by Region (US$ Million) & (2027-2032) Table 142. SAMEA Infectious Waste Treatment Revenue by Type (2021-2026) & (US$ Million) Table 143. SAMEA Infectious Waste Treatment Revenue by Type (2027-2032) & (US$ Million) Table 144. SAMEA Infectious Waste Treatment Revenue by Application (2021-2026) & (US$ Million) Table 145. SAMEA Infectious Waste Treatment Revenue by Application (2027-2032) & (US$ Million) Table 146. SAMEA Infectious Waste Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. SAMEA Infectious Waste Treatment Revenue by Country (2021-2026) & (US$ Million) Table 148. SAMEA Infectious Waste Treatment Revenue by Country (US$ Million) & (2027-2032) Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Infectious Waste Treatment Image Figure 2. Global Infectious Waste Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Infectious Waste Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Equipment Image Figure 5. Service Image Figure 6. Global Infectious Waste Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Infectious Waste Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pathological Waste Treatment Image Figure 9. Sharps Waste Treatment Image Figure 10. Blood-Contaminated Waste Treatment Image Figure 11. Laboratory Infectious Waste Treatment Image Figure 12. Others Image Figure 13. Global Infectious Waste Treatment Market Size (US$ Million) & (2021-2032) Figure 14. Global Infectious Waste Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Infectious Waste Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Infectious Waste Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Infectious Waste Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Infectious Waste Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Infectious Waste Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Infectious Waste Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Infectious Waste Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Infectious Waste Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America Infectious Waste Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Infectious Waste Treatment Revenue Share by Type (2021-2032) Figure 26. North America Infectious Waste Treatment Revenue Share by Application (2021-2032) Figure 27. North America Infectious Waste Treatment Revenue Share by Country (2021-2032) Figure 28. United States Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Infectious Waste Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Infectious Waste Treatment Revenue Share by Type (2021-2032) Figure 33. Europe Infectious Waste Treatment Revenue Share by Application (2021-2032) Figure 34. Europe Infectious Waste Treatment Revenue Share by Country (2021-2032) Figure 35. Germany Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Infectious Waste Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Infectious Waste Treatment Revenue Share by Type (2021-2032) Figure 45. China Infectious Waste Treatment Revenue Share by Application (2021-2032) Figure 46. Asia Infectious Waste Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Infectious Waste Treatment Revenue Share by Type (2021-2032) Figure 48. Asia Infectious Waste Treatment Revenue Share by Application (2021-2032) Figure 49. Asia Infectious Waste Treatment Revenue Share by Region (2021-2032) Figure 50. Japan Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Infectious Waste Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Infectious Waste Treatment Revenue Share by Type (2021-2032) Figure 58. SAMEA Infectious Waste Treatment Revenue Share by Application (2021-2032) Figure 59. SAMEA Infectious Waste Treatment Revenue Share by Country (2021-2032) Figure 60. Brazil Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Infectious Waste Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Equipment
  • Service
Applications
  • Pathological Waste Treatment
  • Sharps Waste Treatment
  • Blood-Contaminated Waste Treatment
  • Laboratory Infectious Waste Treatment
  • Others
Companies covered
  • Veolia
  • Tesalys
  • AMB
  • BEMIS Health Care
  • Bertin Technologies/CNIM
  • Bondtech
  • Celitron Medical Technologies
  • COMTEM
  • Red Bag Solutions
  • Envomed
  • Gient
  • J&T Recycling Corporation
  • Kayama Kogyo Co., Ltd
  • HOMEX.Co.,Ltd
  • KINSEI SANGYO CO.,LTD
  • TAKUMA Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Infectious Waste Treatment Market by Type
  3. 1.2.1 Global Infectious Waste Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Equipment
  5. 1.2.3 Service
  6. 1.3 Infectious Waste Treatment Market by Application
  7. 1.3.1 Global Infectious Waste Treatment Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pathological Waste Treatment
  9. 1.3.3 Sharps Waste Treatment
  10. 1.3.4 Blood-Contaminated Waste Treatment
  11. 1.3.5 Laboratory Infectious Waste Treatment
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Infectious Waste Treatment Market Dynamics
  1. 2.1 Infectious Waste Treatment Industry Trends
  2. 2.2 Infectious Waste Treatment Industry Drivers
  3. 2.3 Infectious Waste Treatment Industry Opportunities and Challenges
  4. 2.4 Infectious Waste Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Infectious Waste Treatment Market Perspective (2021-2032)
  2. 3.2 Global Infectious Waste Treatment Growth Trends by Region
  3. 3.2.1 Global Infectious Waste Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Infectious Waste Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Infectious Waste Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Infectious Waste Treatment Revenue by Players
  2. 4.1.1 Global Infectious Waste Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Infectious Waste Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Infectious Waste Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Infectious Waste Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Infectious Waste Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Infectious Waste Treatment Players, Product Type & Application
  8. 4.5 Global Infectious Waste Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Infectious Waste Treatment Market CR5 and HHI
  11. 4.6.3 2025 Infectious Waste Treatment Tier 1, Tier 2, and Tier 3
5 Infectious Waste Treatment Market Size by Type
  1. 5.1 Global Infectious Waste Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Infectious Waste Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Infectious Waste Treatment Revenue Market Share by Type (2021-2032)
6 Infectious Waste Treatment Market Size by Application
  1. 6.1 Global Infectious Waste Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Infectious Waste Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Infectious Waste Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Veolia
  2. 7.1.1 Veolia Company Information
  3. 7.1.2 Veolia Business Overview
  4. 7.1.3 Veolia Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Veolia Infectious Waste Treatment Product Portfolio
  6. 7.1.5 Veolia Recent Developments
  7. 7.2 Tesalys
  8. 7.2.1 Tesalys Company Information
  9. 7.2.2 Tesalys Business Overview
  10. 7.2.3 Tesalys Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Tesalys Infectious Waste Treatment Product Portfolio
  12. 7.2.5 Tesalys Recent Developments
  13. 7.3 AMB
  14. 7.3.1 AMB Company Information
  15. 7.3.2 AMB Business Overview
  16. 7.3.3 AMB Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 AMB Infectious Waste Treatment Product Portfolio
  18. 7.3.5 AMB Recent Developments
  19. 7.4 BEMIS Health Care
  20. 7.4.1 BEMIS Health Care Company Information
  21. 7.4.2 BEMIS Health Care Business Overview
  22. 7.4.3 BEMIS Health Care Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BEMIS Health Care Infectious Waste Treatment Product Portfolio
  24. 7.4.5 BEMIS Health Care Recent Developments
  25. 7.5 Bertin Technologies/CNIM
  26. 7.5.1 Bertin Technologies/CNIM Company Information
  27. 7.5.2 Bertin Technologies/CNIM Business Overview
  28. 7.5.3 Bertin Technologies/CNIM Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Bertin Technologies/CNIM Infectious Waste Treatment Product Portfolio
  30. 7.5.5 Bertin Technologies/CNIM Recent Developments
  31. 7.6 Bondtech
  32. 7.6.1 Bondtech Company Information
  33. 7.6.2 Bondtech Business Overview
  34. 7.6.3 Bondtech Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bondtech Infectious Waste Treatment Product Portfolio
  36. 7.6.5 Bondtech Recent Developments
  37. 7.7 Celitron Medical Technologies
  38. 7.7.1 Celitron Medical Technologies Company Information
  39. 7.7.2 Celitron Medical Technologies Business Overview
  40. 7.7.3 Celitron Medical Technologies Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Celitron Medical Technologies Infectious Waste Treatment Product Portfolio
  42. 7.7.5 Celitron Medical Technologies Recent Developments
  43. 7.8 COMTEM
  44. 7.8.1 COMTEM Company Information
  45. 7.8.2 COMTEM Business Overview
  46. 7.8.3 COMTEM Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 COMTEM Infectious Waste Treatment Product Portfolio
  48. 7.8.5 COMTEM Recent Developments
  49. 7.9 Red Bag Solutions
  50. 7.9.1 Red Bag Solutions Company Information
  51. 7.9.2 Red Bag Solutions Business Overview
  52. 7.9.3 Red Bag Solutions Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Red Bag Solutions Infectious Waste Treatment Product Portfolio
  54. 7.9.5 Red Bag Solutions Recent Developments
  55. 7.10 Envomed
  56. 7.10.1 Envomed Company Information
  57. 7.10.2 Envomed Business Overview
  58. 7.10.3 Envomed Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Envomed Infectious Waste Treatment Product Portfolio
  60. 7.10.5 Envomed Recent Developments
  61. 7.11 Gient
  62. 7.11.1 Gient Company Information
  63. 7.11.2 Gient Business Overview
  64. 7.11.3 Gient Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Gient Infectious Waste Treatment Product Portfolio
  66. 7.11.5 Gient Recent Developments
  67. 7.12 J&T Recycling Corporation
  68. 7.12.1 J&T Recycling Corporation Company Information
  69. 7.12.2 J&T Recycling Corporation Business Overview
  70. 7.12.3 J&T Recycling Corporation Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  71. 7.12.4 J&T Recycling Corporation Infectious Waste Treatment Product Portfolio
  72. 7.12.5 J&T Recycling Corporation Recent Developments
  73. 7.13 Kayama Kogyo Co., Ltd
  74. 7.13.1 Kayama Kogyo Co., Ltd Company Information
  75. 7.13.2 Kayama Kogyo Co., Ltd Business Overview
  76. 7.13.3 Kayama Kogyo Co., Ltd Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Kayama Kogyo Co., Ltd Infectious Waste Treatment Product Portfolio
  78. 7.13.5 Kayama Kogyo Co., Ltd Recent Developments
  79. 7.14 HOMEX.Co.,Ltd
  80. 7.14.1 HOMEX.Co.,Ltd Company Information
  81. 7.14.2 HOMEX.Co.,Ltd Business Overview
  82. 7.14.3 HOMEX.Co.,Ltd Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  83. 7.14.4 HOMEX.Co.,Ltd Infectious Waste Treatment Product Portfolio
  84. 7.14.5 HOMEX.Co.,Ltd Recent Developments
  85. 7.15 KINSEI SANGYO CO.,LTD
  86. 7.15.1 KINSEI SANGYO CO.,LTD Company Information
  87. 7.15.2 KINSEI SANGYO CO.,LTD Business Overview
  88. 7.15.3 KINSEI SANGYO CO.,LTD Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  89. 7.15.4 KINSEI SANGYO CO.,LTD Infectious Waste Treatment Product Portfolio
  90. 7.15.5 KINSEI SANGYO CO.,LTD Recent Developments
  91. 7.16 TAKUMA Co., Ltd
  92. 7.16.1 TAKUMA Co., Ltd Company Information
  93. 7.16.2 TAKUMA Co., Ltd Business Overview
  94. 7.16.3 TAKUMA Co., Ltd Infectious Waste Treatment Revenue and Gross Margin (2021-2026)
  95. 7.16.4 TAKUMA Co., Ltd Infectious Waste Treatment Product Portfolio
  96. 7.16.5 TAKUMA Co., Ltd Recent Developments
8 North America
  1. 8.1 North America Infectious Waste Treatment Revenue (2021-2032)
  2. 8.2 North America Infectious Waste Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Infectious Waste Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Infectious Waste Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Infectious Waste Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Infectious Waste Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Infectious Waste Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Infectious Waste Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Infectious Waste Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Infectious Waste Treatment Revenue by Country
  11. 8.6.1 North America Infectious Waste Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Infectious Waste Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Infectious Waste Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Infectious Waste Treatment Revenue (2021-2032)
  2. 9.2 Europe Infectious Waste Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Infectious Waste Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Infectious Waste Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Infectious Waste Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Infectious Waste Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Infectious Waste Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Infectious Waste Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Infectious Waste Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Infectious Waste Treatment Revenue by Country
  11. 9.6.1 Europe Infectious Waste Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Infectious Waste Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Infectious Waste Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Infectious Waste Treatment Revenue (2021-2032)
  2. 10.2 China Infectious Waste Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Infectious Waste Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Infectious Waste Treatment Revenue by Type (2027-2032)
  5. 10.3 China Infectious Waste Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Infectious Waste Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Infectious Waste Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Infectious Waste Treatment Revenue by Application (2027-2032)
  9. 10.5 China Infectious Waste Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Infectious Waste Treatment Revenue (2021-2032)
  2. 11.2 Asia Infectious Waste Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Infectious Waste Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Infectious Waste Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Infectious Waste Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Infectious Waste Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Infectious Waste Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Infectious Waste Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Infectious Waste Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Infectious Waste Treatment Revenue by Country
  11. 11.6.1 Asia Infectious Waste Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Infectious Waste Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Infectious Waste Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Infectious Waste Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Infectious Waste Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Infectious Waste Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Infectious Waste Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Infectious Waste Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Infectious Waste Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Infectious Waste Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Infectious Waste Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Infectious Waste Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Infectious Waste Treatment Revenue by Country
  11. 12.6.1 SAMEA Infectious Waste Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Infectious Waste Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Infectious Waste Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst